Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Increasing sebum production might help reduce fat and improve metabolism.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

A hair-growth formula with cystine and thiamin helps protect skin cells against UV damage and improves their growth.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

People with androgenetic alopecia are more likely to have metabolic syndrome.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Cannabis has anti-inflammatory and antimicrobial properties, but more research is needed on its effects on plant and aquatic animal pathogens.

The study found that heart disease is common in people with PCOS and that being overweight is a major risk factor; lifestyle changes and medication are important for management.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

PCOS leads to various immediate and long-term health problems, affecting quality of life and increasing costs.

High insulin levels are more common and a better predictor of carbohydrate issues in women with PCOS than glucose tolerance tests.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.